Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check6 days agoChange DetectedRemoved the 'Multiple myeloma' label, the 'related topics:' header, and the 'MedlinePlus Genetics' entry from the Related Topics section.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now includes a related topics section featuring 'Multiple myeloma' and a link to MedlinePlus Genetics, providing quick access to disease- and genetics-related information.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a new revision tag: Revision: v3.6.3. Removed several items from the related topics section, including 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.2'.SummaryDifference0.2%

- Check28 days agoChange DetectedA new Revision: v3.6.2 entry was added to the page's revision history, and the previous Revision: v3.6.0 entry was removed. This update reflects a newer version of the page's metadata without altering the content or functionality.SummaryDifference0.0%

- Check35 days agoChange DetectedA Related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics', linking to disease context and genetics resources. This helps users access background information and genetics-related materials more easily.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now indicates that no participants are being sought, signaling that enrollment is closed. In addition, new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the revision note was updated to v3.6.0, and the Intervention/Treatment heading was reformatted (Intervention / Treatment removed in favor of Intervention/Treatment).SummaryDifference0.5%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.